Arch Phys Med 87:1365–1370PubMedCrossRef Gross DP, Battié MC (2004)
The prognostic value of Functional Capacity Evaluation in patients with chronic low back pain: part 2; sustained recovery. Spine 29:920–924PubMedCrossRef Gross DP, Battié MC (2005) Functional Capacity Evaluation performance does not predict sustained return to work in claimants with chronic back pain. J Occup Rehab 15:285–294CrossRef Gross DP, Battié MC (2006) Does Functional Capacity Evaluation predict recovery in workers’ compensation claimants with upper extremity selleck products disorders? Occup Environ Med 3:404–410CrossRef Gross DP, Battié MC, Cassidy JD (2004) The prognostic value of Functional Capacity Evaluation in patients with chronic low back pain: part 1; timely return to work. Spine 29:914–919PubMedCrossRef Gross DP, Battié MC, Asante A (2006) Development and validation of a short-form Functional Capacity Selleck Androgen Receptor Antagonist Evaluation for use in claimants with low back disorders. J Occup Rehab 16:53–62CrossRef Harten JA (1998) Functional capacity evaluation. Occup Med 13:209–212PubMed Hudson-Cook N, Tomes-Nicholson K, Breen A (1989) A revised Oswestry disability questionnaire. In: Roland M, Jenner JR (eds) Back pain: new approaches to rehabilitation and education. Manchester University Press, Manchester, pp 187–204 Innes E (2006) Reliability and Tubastatin A purchase Validity of functional capacity evaluations:
an update. Int J Disab Manag Res 1:135–148CrossRef Innes E, Straker L (1999a) Reliability of work-related assessments.
Work 13:107–124PubMed Innes E, Straker L (1999b) Validity of work-related assessments. Work 13:125–152PubMed Kerstholt JH, de Boer WEL, Jansen EJM, Bollen D, Rasker PC, Cremer R (2002) Psychological aspects of disability claim assessment (Psychologische aspecten van de claimbeoordeling: in Dutch). TNO report, TM-02-C051, Hoofddorp, p 33 King PM, Tuckwell N, Barrett TE (1998) A critical review of functional capacity evaluations. Phys Ther 78(8):852–866PubMed Le Pen C, Reygrobellet C, Gérentes Orotidine 5′-phosphate decarboxylase I (2005) Financial cost of osteoarthritis in France. The COART France study. Joint Bone Spine 72:567–570PubMedCrossRef Lubeck DP (2003) The costs of musculoskeletal disease: health needs assessment and health economics. Best Pract Res Clin Rheum 17:529–539CrossRef Lyth JR (2001) Disability management and functional capacity evaluation: a dynamic resource. Work 16:13–22PubMed Statistics Netherlands (2004) Labour, income and social security (in Dutch). http://www.cbs.nl/theme Picavet S, Schouten JSAG (2003) Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC3-study. Pain 102:167–178PubMedCrossRef Rainville J, Pransky G, Indahl A, Mayer EK (2005) The physician as disability advisor for patients with musculoskeletal complaints.